Skip to main content
. 2022 Dec 2;82(2):110–119. doi: 10.1093/jnen/nlac115

Table 2.

Comparison of pathologies in cognitively normal individuals and cognitively impaired individuals

Cognitively normal (CDR = 0; n = 79) Cognitively impaired (CDR ≥ 0.5; n = 625) p value
ADNC, Int-High 27 (34.2%) 435 (69.6%) <0.0001
LATE-NC, stages 2–3 11 (13.9%) 204 (32.6%) 0.0004
LBD, stages 2–3 17 (21.5%) 146 (23.4%) 0.7785
Cerebrovascular disease 39 (43.8%) 289 (46.2%) 0.6331
At least 1 proteinopathy 44 (55.7%) 530 (84.8%) <0.0001
Multiple proteinopathies 13 (16.5%) 221 (35.4%) 0.0006
At least 1 pathology 46 (58.2%) 541 (86.6%) 0.0208
Multiple pathologies 15 (19.0%) 260 (41.6%) <0.0001